mGluR3 NAMs are also found to be efficacious in preventing motivational deficits and changes in the amygdalo-cortical plasticity (Joffe et al. 2019), suggesting the potential utility of mGluR3 NAMs for treating psychiatric disorders. This evidence concerns the gene GRM3 and psychiatric disorder.